MedTech Strategist: Signum Surgical Advances Unique Solution for an Overlooked Problem
Signum Surgical is featured in the July/August 2026 issue of MedTech Strategist as one of the publication’s “Start-Ups to Watch.” The in-depth profile highlights the company’s innovative approach to treating anal fistula with BioHealx®, a bioabsorbable implant that closes the anal fistula tract through extraluminal compression, without cutting the sphincter muscle. It also highlights the company’s mission to improve outcomes for patients living with this challenging condition.
“We’re honored to be recognized by MedTech Strategist as a company to watch,”
said Carol Burns, CEO of Signum Surgical.
“This recognition reflects the dedication of our team and our commitment to advancing innovation in colorectal surgery.”
We thank the editors of MedTech Strategist for highlighting our work and look forward to continuing to advance the BioHealx medical device through clinical development and commercialization. The article can be accessed by MedTech Strategist subscribers, others can access a short preview of the article here: